EDUCATION & TRAINING:

Undergraduate

  • 1986-1990    Bachelor of Science in Biology
    Baylor University, Waco, TX, 76798

Graduate

  • 1990-1991    Master of Arts in Biology
    Baylor University, Waco, TX
  • 1991-1995    Doctor of Medicine
    University of Texas Medical Branch, Galveston, TX

Post-Doctoral Education

  • 1995-1998    Internal Medicine Residency
    University of Texas Medical Branch, Galveston, TX
  • 1998-2001     Cardiology Fellowship   
    University of Texas Medical Branch, Galveston, TX

EXPERIENCE/SERVICE:

Academic Appointments

  • 1990-1991        General Biology/Animal Physiology
    Lab Instructor, Department of Biology, Baylor University, Waco, TX
  • 1992-1993        Anesthesia Research
  • Clinical Research Assistant II
    UTMB, Department of Anesthesia, Galveston, TX
  • 9/1999-6/2001    Emergency Medicine
  • Clinical Assistant Instructor
    UTMB, Department of Surgery, Galveston, TX
  • 7/2001-2/2004    General Cardiology/Heart Failure
  • Assistant Professor of Medicine (non-tenure track)
    UTMB, Division of Cardiology, Galveston, TX
  • 2/2004-2/2008    General Cardiology/Heart Failure
  • Assistant Professor of Medicine
    MDACC, Department of Cardiology, Houston, TX

Other Appointments/Responsibilities

  • 2000-2001        Pharmacy and Therapeutics Committee, UTMB
  • 2001-2004        Institutional Review Board, UTMB
  • 2002-2004        American Heart Association Board of Directors, Galveston Chapter
  • 2005-2008        Clinical Research Committee II Review Board
  • 2006-2008        Perioperative Medicine Multidisciplinary Working Group
  • 2007-2008        Clinical Quality Improvement Council, QI Officer for Cardiology
  • 2007-2008        Clinical Effectiveness Committee of the Medical Staff

Active Consultantships:

  • 04/2002-present    Novartis Pharmaceuticals, USA, Consultant for Research Development/Medical Consultant/Speaker

RESEARCH ACTIVITIES:

Departmentally Sponsored Trials

  • 2006    A Retrospective Analysis of Cancer Patients in Atrial Fibrillation/Flutter Receiving Ibutilide to Evaluate Safety and Efficacy
  • 2003-2004    Blood Flow Measurements in Young and Elderly Subjects Using the Contrast Enhanced Ultrasound Technique, Co-investigator with Melinda Sheffield-Moore, Ph.D
  • 2003-2004    Prevalence of growth hormone deficiency in patients with idiopathic dilated cardiomyopathy, Co-investigator with D. Lackan, MD
  • 1999-2001    Effect of a multidisciplinary approach to heart failure management, Co-investigator with D. Lenihan, MD
  • 1999-2000    Maximum-tolerated doses of cyclin kinase inhibitor flavopiridol: potential role in limiting in-stent restenosis, Co-investigator with C. Patterson, MD
  • 1997-1998    Use of the signal-averaged electrocardiogram in stress testing for ischemic heart disease, Co-investigator with R. Sheahan, MD and R. Belt, MD
  • 1992-1993    Fluid resuscitation of critically-stressed swine: cardiac edema and volume assessment, research under G. Kramer, PhD
  • 1990-1991    Diurnal variation of serotonin in rats, under R. Wilson, PhD (mentor)

National Multicenter Trials

  • 2006    Darbepoetin alfa Treatment on Mortality & Morbidity in Heart Failure (HF) Subjects w/Symptomatic Left Ventricular Systolic Dysfunction & Anemia
  • 2002-2004        ADHERE: Acutely Decompensated Heart Failure Registry Sponsored by Scios, Inc.
  • 1999-2004    SCD-HeFT: Sudden Cardiac Death in Heart Failure Trial Sponsored by NHLBI, Medtronic, Inc. and Wyeth-Ayerst Laboratories
  • 2000-2002    RITZ-4: Effect of Tezosentan in Acute HF Associated with ACS Sponsored by Actelion Ltd.,
  • 2000-2004     WATCH Trial: Warfarin and Antiplatelet Therapy in Chronic Heart Failure.